Cigna (CI) Stock Forecast & Price Target

Cigna Group is expected to have strong growth in its core business lines, aided by the recent merger with Express Scripts and lucrative contracts with major insurers and government entities. The company's expanded PBM services and growing specialty drug capabilities should continue to drive earnings growth. Additionally, Cigna's emphasis on improving access, cost, and quality of care, as well as its focus on addressing health disparities, may attract sustainability-oriented investors. Despite overcoming challenges in the PBM space and exiting its Marketplace business, Cigna's diverse offerings and prudent approach to expectations make it an attractive investment opportunity, with potential for further multiple expansion.

Cigna Group is expected to face headwinds in their pharmacy benefit management (PBM) segment due to significant declines in quarterly earnings. Additionally, with low-bar expectations, it will be a challenge for Cigna to maintain their growth target in the Specialty and Care Services segment. Furthermore, the company's decision to exit the individual ACA exchange business at the end of 2026 reveals a strategic move to increase profitability in the long run, but also highlights potential challenges in this market.